ARTICLE | Clinical News
Cogane: Phase II data
February 25, 2013 8:00 AM UTC
Top-line data from the double-blind, international Phase II CONFIDENT-PD trial in over 400 patients with early stage PD showed that once-daily 60, 120 and 180 mg doses of oral Cogane for up to 28 week...